ATX-2207Phase IIStage III NSCLC, neoadjuvantStructural profileComplexity64Amendment burden3 amendmentsOperational ambiguity31Visit burden18 visits
ATX-3104Phase IIIRefractory MDD with comorbid anxietyStructural profileComplexity88Amendment burden6 amendmentsOperational ambiguity58Visit burden26 visits
ATX-4011Phase IIEarly-onset Parkinson's, biomarker-stratifiedStructural profileComplexity72Amendment burden4 amendmentsOperational ambiguity44Visit burden22 visits